ARTICLE | Company News
Beactica, J&J deal
December 10, 2012 8:00 AM UTC
Johnson & Johnson's Janssen Pharmaceutica N.V. unit and Beactica added the use of Beactica's Sprint surface plasmon resonance (SPR) to identify allosteric modulators targeting undisclosed CNS proteins...